We believe that JATENZO® has the potential to be a preferred option amongst available T-replacement therapies for appropriate hypogonadal men.
JATENZO is a proprietary softgel capsule that contains a testosterone (T) prodrug, T undecanoate, or TU, formulated to foster absorption via the intestinal lymphatic system. After oral TU is absorbed, endogenous enzymes in the body cause T to be released from the prodrug. This proprietary formulation enhances the bioavailability of TU and reduces the impact of food on the absorption.
We believe JATENZO will offer hypogonadal men and prescribing physicians a safe and effective oral T-replacement option and will have a number of advantages over the currently approved T-replacement therapies, including:
- Convenient Oral Dosing. JATENZO is one or two easy-to-swallow softgel capsules taken twice daily with a meal.
- No Inadvertent T Exposure. JATENZO is an oral product that eliminates the risk of transfer of T to women and children associated with the T gels.
- Normalized T Levels. After appropriate dose adjustment, 87% of men treated with JATENZO in the inTUne trial achieved average circulating levels of T in the normal range for men
- Safety Profile. JATENZO's adverse events profile is consistent with other T replacement therapies. JATENZO therapy can cause BP increases. See Important Safety Information for details.